Methylphenidate Treatment of Cancer-Related Fatigue
The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.
Cancer-related Fatigue
DRUG: Methylphenidate hydrochloride|DRUG: Placebo
General Fatigue measured by the Multidimensional Fatigue Inventory (Subscale General Fatigue), 6 weeks
Quality of Life (EORTC-QLQ C30), 6 weeks
The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.